Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

43.53
Delayed Data
As of May 24
 -0.15 / -0.34%
Today’s Change
36.76
Today|||52-Week Range
45.84
+13.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line615.0M-329.0M798.0M419.0M
 
 
 
 
 
Depreciation347.0M340.0M319.0M774.0M
 
 
 
 
 
Total Other Cash Flow62.0M1.0B297.0M563.0M
 
 
 
 
 
Funds From Operations1.0B1.0B1.4B1.8B
 
 
 
 
 
Extraordinary Items0.000.000.00-1.2B
 
 
Funds From/For Other Operating Expenses115.0M-206.0M244.0M31.0M
 
 
 
 
 
Net Cash Flow - Operating Activities909.0M1.2B1.2B574.0M
 
 
 
 
 
 
InvestingIncrease In Investments---182.0M-1.8B-15.0M
 
 
 
 
Decrease In Investments----3.7B1.7B
 
 
 
Capital Expenditures-247.0M-312.0M-319.0M-272.0M
 
 
 
 
 
Fixed Asset Disposal0.000.000.005.5B
 
 
Net Assets From Acquisitions ---66.0M-7.0M-13.0B
 
 
 
 
Other Investing - Sources--6.0M8.0M3.0M
 
 
 
 
Net Cash Flow Investing-1.5B-554.0M1.6B-6.2B
 
 
 
 
 
 
FinancingShort Term Borrowings298.0M-397.0M-1.1B-1.5B
 
 
 
 
 
Long Term Borrowings-132.0M-38.0M15.1B0.00
 
 
 
 
Long Term Debt Reduction-3.0M-1.0M-1.0M-2.5B
 
 
 
 
 
Net Proceeds Stock Sale43.0M76.0M42.0M129.0M
 
 
 
 
 
Common Preferred Redeemed-1.0M-2.0M0.00-95.0M
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-384.0M-384.0M-386.0M-460.0M
 
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing0.000.00170.0M13.0M
 
 
 
Net Cash Flow - Financing-179.0M-746.0M13.5B-4.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-16.0M5.0M-104.0M65.0M
 
 
 
 
 
 
Net Change In Cash-740.0M-83.0M16.2B-10.0B